From Biognosys Jun 26 2026 Reviewed The  Biognosys Group , a leader in mass spectrometry-based multiomics, announces advancements across its integrated multiomics portfolio, highlighting next-generation software, sample preparation, enrichment, and separation technologies for proteomics and metabolomics. With the launch of  Spectronaut  21 and  SpectroMine  6, continued innovation in ultrasensitive targeted assays, and optimized workflows including  iST-S ,  P2  single-particle enrichment, FFPE